Written by: PhD Student Cristina Valle-Hita and Prof. Jordi Salas-Salvadó
Hyperuricemia is an important health condition but is usually undervalued, which appears when serum uric acid (SUA) accumulates in the body (1,2). This compound is the final product of the endogenous purine metabolism in the liver of humans and it is mainly excreted by kidneys and a minor portion via intestines (2,3). Hence, an abnormality in one of these procedures or a combination may be the onset of this disorder (1–3). Despite this, there is no consensus about the definition of hyperuricemia, usually, concentrations higher than 6.8 mg/dL in blood are considered abnormally high (hyperuricemia) (1).
It is estimated that around 20% of the global population is affected by hyperuricemia and over the last few years, its prevalence has been rapidly growing (3,4). Although some people do not exhibit any signs or symptoms of SUA accumulation, many of them suffer gout, the most common painful joint disease owing to uric acid accumulation in blood and tissues (1,3,5,6). In addition, previously hyperuricemia has been positively associated with several comorbidities with a huge impact on people’s health and quality of life, especially with the incidence of cardiovascular diseases, but also other cardiometabolic conditions such as hypertension, obesity, metabolic syndrome, and diabetes (1,2,6). Hyperuricemia has also been frequently used as a biomarker of renal function decline. Therefore, the application of appropriate preventive measures in order to avoid high accumulation levels of SUA in the human body may contribute to reducing the adverse conditions associated with this condition and therefore the burden of the healthcare system.
In view of what has been previously mentioned, it is crucial to identify the potential risk factors for developing hyperuricemia. Age, sex, genetics, and other modifiable factors such as lifestyle habits, medication use, and socioeconomic status are recognized risk factors of hyperuricemia and gout (3,6,7). However, the recent remarkable increase of SUA levels in developed countries in the last years has been attributed to changes in lifestyle and, particularly, in dietary habits (5,7). In fact, a low-purine diet is considered one of the first choices to treat hyperuricemia, which means a reduction of meat, seafood, alcohol, and sweets consumption and an increase of vitamin C intake and fiber-rich foods such as fruits and vegetables (6). Moreover, antioxidant and anti-inflammatory properties of some foods and plant-based dietary patterns may also improve SUA concentrations (8). Thus, previous studies showed that greater adherence to the Mediterranean Diet is associated with lower hyperuricemia risk (9,10), as well as several individual components of the diet such as vegetables, fruits, coffee, low-fat dairy products, soy foods (5,7), and other foods as legumes (11), which in the last decades have been an object of concern because of their high content in purines.
There is an increasing number of studies focused on nuts, which reported the beneficial effect of their consumption in human health through decreasing the risk of different chronic diseases (12). In addition, nowadays, there is widespread evidence that even though this food group is high in calories, they are dense and full of beneficial nutrients. Nuts are rich in healthy unsaturated fatty acids, vegetable proteins, vitamins, minerals, fiber, and other substances with potential antioxidant and anti-inflammatory effects, such as carotenoids and phytosterols (12,13), which may partly explain their protective effects on different health outcomes, such as cardiovascular diseases, diabetes, obesity, hypertension, and metabolic syndrome (12). Nevertheless, given that only a few investigations have focused on the influence of nut consumption on hyperuricemia, little is widely known.
To the best of our knowledge, there is an exclusive paper, which cross-sectionally studied the association between different types of nuts and the risk of hyperuricemia. The authors of this study reported, for the first time, that the consumption of some specific nuts, particularly pine nuts and walnuts, was associated with a lower risk of hyperuricemia in a sample of 14,056 Chinese young adults (13). Furthermore, in a randomized controlled clinical trial of 150 middle-aged patients with coronary artery disease, it has been shown that those participants in the intervention group supplemented with almonds significantly decreased SUA levels compared to those avoiding the consumption of nuts after 6 and 12 weeks of follow-up (14). Hence, the potential beneficial effect of consuming nuts in order to avoid hyperuricemia was demonstrated.
In summary, although the fact that nuts can confer protection against chronic diseases is well recognized, the current evidence regarding the association between nut consumption and hyperuricemia is limited. However, these preliminary study results are encouraging and they suggest that nuts could be an important food group to include in the diet to prevent hyperuricemia onset or even its progression. Taking into consideration that hyperuricemia prevention may provide protection to cardiovascular, renal, and other diseases, nuts consumption within a healthy diet could allow great benefits for human health. Consequently, further clinical trials and prospective studies are warranted to confirm the prior aforementioned study results and future investigations should be focused on this novel line of research.
References
1. George C, Minter DA. Hyperuricemia. [Updated 2021 Jul 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459218/
2. Mallat SG, Al Kattar S, Tanios BY, Jurjus A. Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association. Curr Hypertens Rep. 2016;18(10).
3. Baker JF, Ralph Schumacher H. Update on gout and hyperuricemia. Int J Clin Pract. 2010;64(3):371–7.
4. Ali N, Perveen R, Rahman S, Mahmood S, Rahman S, Islam S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults. PLoS One. 2018;13(11):1–12.
5. Álvarez-Lario B, Alonso-Valdivielso JL. Hyperuricemia and gout; the role of diet. Nutr Hosp. 2014;29(4):760–70.
6. Petreski T, Ekart R, Hojs R, Bevc S. Hyperuricemia, the heart, and the kidneys–to treat or not to treat? Ren Fail. 2020;42(1):978–86.
7. Li R, Yu K, Li C. Dietary factors and risk of gout and hyperuricemia: A meta-analysis and systematic review. Asia Pac J Clin Nutr. 2018;27(6):1344–56.
8. Jakše B, Jakše B, Pajek M, Pajek J. Uric Acid and Plant-Based Nutrition. Nutrients. 2019;11(8):1736.
9. Stamostergiou J, Theodoridis X, Ganochoriti V, Bogdanos D, Sakkas L. The role of the Mediterranean diet in hyperuricemia and gout. Mediterr J Rheumatol. 2018;29(1):21–5.
10. Guasch-Ferré M, Bulló M, Babio N, Martínez-González MA, Estruch R, Covas MI, et al. Mediterranean diet and risk of hyperuricemia in elderly participants at high cardiovascular risk. Journals Gerontol – Ser A Biol Sci Med Sci. 2013;68(10):1263–70.
11. Becerra-Tomás N, Mena-Sánchez G, Díaz-López A, Martínez-González MÁ, Babio N, Corella D, et al. Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study. Eur J Nutr. 2020;59(5):2195–206.
12. De Souza RGM, Schincaglia RM, Pimente GD, Mota JF. Nuts and human health outcomes: A systematic review. Nutrients. 2017;9(12):1311.
13. Wang C, Guo XF, Yang T, Zhao T, Li D. Nut intake and hyperuricemia risk in young adults. Public Health Nutr. 2021;1-7.
14. Jamshed H, Gilani AUH, Sultan FAT, Amin F, Arslan J, Ghani S, et al. Almond supplementation reduces serum uric acid in coronary artery disease patients: A randomized controlled trial. Nutr J. 2016;15(1):10–4.